Missing: Comprehensive NeuroScience's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Comprehensive NeuroScience's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Comprehensive NeuroScience News
Apr 6, 2022
USA - English Share this article and neurologists NEW YORK, April 6, 2022 /PRNewswire/ -- Aidoc , the leading provider of healthcare AI solutions, announced today that it received its 9th FDA 510(k) clearance for triage and notification of brain aneurysm. This announcement further strengthens Aidoc's position as the leading provider of the most comprehensive, enterprise-grade clinical AI platform, including the broadest neuroscience suite offered to clinicians around the world. One out of 50 people suffer from a brain aneurysm in the U.S. each year. Overlooked 10 percent of the time, incidental positive cases often go unnoticed due to their small size and complexity of blood vessels in the brain. If ruptured, patients face a 50 percent chance of fatality. Adding to its repertoire of neuro solutions that include LVO (M1), ICH and C-spine fractures, Aidoc's newly FDA-cleared solution now flags and communicates suspected positive cases of brain aneurysm. The brain aneurysm solution delivers a care coordination workflow that is tailored to radiologists, neuroendovascular surgeons and neurologists, who need to treat multiple and different types of patients, whether from the emergency room, outpatients, at the hub, or transfered from the spoke. "In the U.S., there is tragically a brain aneurysm rupture every 18 minutes. It's an acute condition that can quickly turn fatal, so time is of the essence, especially for late night reading," said Elad Walach, Co-founder and CEO of Aidoc. "We're excited to include this algorithm in our set of neuro solutions, addressing the challenge of providing timely and accurate notifications of brain aneurysm cases. With this 9th FDA clearance in three years, we stay committed to providing the most comprehensive platform in the space. " Aidoc's AI platform enables seamless addition of new AI solutions as a native part of the workflow, eliminating the need to train current and new personnel as additional solutions are adopted by the hospital. About Aidoc Aidoc ( aidoc.com ) is the leading provider of artificial intelligence healthcare solutions that empower physicians to expedite patient treatment and enhance efficiencies. Aidoc's AI-driven solutions analyze medical images directly after the patient is scanned, suggesting prioritization of time-sensitive pathologies, as well as notifying and activating multidisciplinary teams to reduce turnaround time, shorten length of stay and improve overall patient outcomes. Netanya Stein
Comprehensive NeuroScience Frequently Asked Questions (FAQ)
Where is Comprehensive NeuroScience's headquarters?
Comprehensive NeuroScience's headquarters is located at White Plains.
What is Comprehensive NeuroScience's latest funding round?
Comprehensive NeuroScience's latest funding round is Seed VC.
How much did Comprehensive NeuroScience raise?
Comprehensive NeuroScience raised a total of $10.3M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.